FDA Inspection 1201208 — AdventHealth Cancer Institute Cellular Therapy Laboratory

AdventHealth Cancer Institute Cellular Therapy Laboratory — FEI 3003926638

The FDA completed an inspection of AdventHealth Cancer Institute Cellular Therapy Laboratory on Mar 23, 2023 in Orlando, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Mar 23, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Orlando, FL (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.